Tag: disease-drug
-
Further promising data seen with Biogen Alzheimer’s drug: study
(Reuters) – Gradually increasing the dose of Biogen Inc’s experimental Alzheimer’s disease drug appeared to reduce the risk of brain swelling compared to higher fixed doses, interim 12-month results from a small study released on Thursday showed. “These data appear solid to us, and if anything provide additional confidence in the program and viability of…
-
Zimmer Biomet to settle bribery charges with U.S. prosecutors: filing
U.S. authorities will reach a settlement with medical device maker Zimmer Biomet Holdings Inc over bribery allegations in the next four weeks, prosecutors said in a court filing Thursday. The new agreement would replace a 2012 settlement with the U.S. Justice Department over allegations that Biomet paid bribes to state-employed healthcare providers in Argentina, Brazil…